GENELUX CORPORATION Payments to Acquire Investments
GENELUX CORPORATION (GNLX) reported Payments to Acquire Investments of $14.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-08-13
- GENELUX CORPORATION payments to acquire investments for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- GENELUX CORPORATION payments to acquire investments for the quarter ending 2026-03-31 was $14.40M, a 485.05% increase year-over-year.
- GENELUX CORPORATION payments to acquire investments for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- GENELUX CORPORATION payments to acquire investments for the quarter ending 2025-09-30 was $5.26M, a 165.62% increase year-over-year.
- GENELUX CORPORATION payments to acquire investments for fiscal 2025 was $18.26M, a 37.03% decline from fiscal 2024.
- GENELUX CORPORATION payments to acquire investments for fiscal 2024 was $29.00M, a 111.69% increase from fiscal 2023.
- GENELUX CORPORATION payments to acquire investments for fiscal 2023 was $13.70M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $14.40M 10-Q · filed 2026-08-13 | $14.40M derived: sum of 3 quarters · filed 2026-08-13 | $19.66M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $14.40M 10-Q · filed 2026-05-07 | $14.40M derived: sum of 2 quarters · filed 2026-05-07 | $19.66M derived: sum of 3 quarters · filed 2026-05-07 | $30.20M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $5.26M derived: sum of 2 quarters · filed 2026-03-19 | $15.80M derived: sum of 3 quarters · filed 2026-08-13 | $18.26M 10-K · filed 2026-03-19 |
| 2025-09-30 | $5.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $15.80M derived: sum of 2 quarters · filed 2026-08-13 | $18.26M 10-Q · filed 2025-11-05 | $18.74M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $10.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $13.00M 10-Q · filed 2026-08-13 | $13.48M derived: sum of 3 quarters · filed 2026-08-13 | $15.46M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $2.46M 10-Q · filed 2026-05-07 | $2.94M derived: sum of 2 quarters · filed 2026-05-07 | $4.92M derived: sum of 3 quarters · filed 2026-05-07 | $28.30M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $2.46M derived: sum of 2 quarters · filed 2026-03-19 | $25.84M derived: sum of 3 quarters · filed 2026-03-19 | $29.00M 10-K · filed 2026-03-19 |
| 2024-09-30 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $25.36M derived: sum of 2 quarters · filed 2025-11-05 | $28.52M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $23.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $26.54M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $3.16M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $13.70M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |